The Effect of Phacoemulsification on the Macular Changes in Patients with Neovascular Age-related Macular Degeneration
it does not
Macular Changes After Phacoemulsification in Patients with Neovascular AMD
1 other identifier
observational
50
0 countries
N/A
Brief Summary
The macula has a very high concentration of photoreceptor cells - the cells that detect light. They send signals to the brain, which interprets them as images. The rest of the retina processes our peripheral, or side vision To explore whether cataract surgery evokes development or relapse of choroidal neovascularization (CNV) in wet age-related macular degeneration (AMD) patients followed for a 1-year postoperative period
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 30, 2024
CompletedFirst Posted
Study publicly available on registry
January 6, 2025
CompletedStudy Start
First participant enrolled
February 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedJanuary 6, 2025
December 1, 2024
1 year
December 30, 2024
December 30, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
To figure out the possibility of Postoperative conversion or relapse ( Dry to wet , wet to reactivated CNV)
To explore whether cataract surgery evokes development or relapse of choroidal neovascularization (CNV) in wet age-related macular degeneration (AMD) patients followed for a 1-year postoperative period
baseline
Eligibility Criteria
old age population had phacoemulsefcation with history of neovascular AMD
You may qualify if:
- Above 50 years old
- not diabetic individuals
- wet ARMD
You may not qualify if:
- intraoperative complications
- Eyes with diseases predisposing them for postoperative macular edema, preexisting macular edema, and eyes that developed cystoid macular edema
- active ocular inflammation or infection \_glaucoma
- A preoperatively worsened VA regardless phE
- ocular trauma
- patients with central retinal ischemia
- previous vitrectomy
- dry amd
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Month
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- doctor
Study Record Dates
First Submitted
December 30, 2024
First Posted
January 6, 2025
Study Start
February 1, 2025
Primary Completion
February 1, 2026
Study Completion
April 1, 2026
Last Updated
January 6, 2025
Record last verified: 2024-12